Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
Business Wire•12/08/2026•08:32 ET
0
Whiz Insights
Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will present at the Midwest IDEAS Investor Conference on Thursday, August 27, 2026, at The InterContinental Chicago in Chicago, IL.
Get started
Create a free account to read the full story.